help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 12, 2003
Endocrinology, doi:10.1210/en.2003-0479
A more recent version of this article appeared on September 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
144/9/3958    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HOLNESS, M. J.
Right arrow Articles by SUGDEN, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOLNESS, M. J.
Right arrow Articles by SUGDEN, M. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Dietary Fats
Hazardous Substances DB
*GLUCOSE

Submitted on April 16, 2003
Accepted on June 3, 2003

Diabetogenic impact of long-chain {omega}-3 fatty acids on pancreatic {beta}-cell function and the regulation of endogenous glucose production

MARK J. HOLNESS1, GEMMA K. GREENWOOD1, NICHOLAS D. SMITH1, and MARY C. SUGDEN1*

1 Department of Diabetes and Metabolic Medicine, Barts and the London, Queen Mary's School of Medicine and Dentistry, University of London, London, U.K.

* To whom correspondence should be addressed. E-mail: m.c.sugden{at}qmul.ac.uk.

In healthy individuals, peripheral insulin resistance evoked by dietary saturated lipid can be accompanied by increased insulin secretion such that glucose tolerance is maintained. Substitution of long-chain {omega}-3 fatty acids for a small percentage of dietary saturated fat prevents insulin resistance in response to high-saturated fat feeding. We substituted a small amount (7%) of dietary lipid with long-chain {omega}-3 fatty acids during 4 weeks of high-saturated-fat feeding to investigate the relationship between amelioration of insulin resistance and glucose-stimulated insulin secretion (GSIS). We demonstrate that, despite dietary delivery of saturated fat throughout, this manipulation prevents high-saturated-fat-feeding induced insulin resistance with respect to peripheral glucose disposal and reverses insulin hypersecretion in response to glucose in vivo. Effects of long-chain {omega}-3 fatty acid enrichment to lower GSIS were also observed in perifused islets suggesting a direct effect on islet function. However, long-chain {omega}-3 fatty acid enrichment led to hepatic insulin resistance with respect to suppression of glucose output and impaired glucose tolerance in vivo. Our data demonstrate that the insulin response to glucose is suppressed to a greater extent than whole-body insulin sensitivity is enhanced by enrichment of a high-saturated fat diet by long-chain {omega}-3 fatty acids. Additionally, reduced GSIS despite glucose intolerance suggests that either long-chain {omega}-3 fatty acids directly impair the {beta}-cell response to saturated fat such that insulin secretion cannot be augmented to normalize glucose tolerance or {beta}-cell compensatory hypersecretion represents a response to insulin resistance at the level of peripheral glucose disposal, but not endogenous glucose production.


Key words: insulin resistance • compensatory insulin secretion • euglycemic clamp • islet perifusion; glucose tolerance







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society